Flyte Aviation, Inc. (VTAK)
- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $1.06
- As of
Kresmion compiles this page from VTAK's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Flyte Aviation, Inc. (VTAK): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-14.
See the full VTAK dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for VTAK on one page. Preview it with sample data, then open it live with a free account.
Preview the VTAK dossierActive signals for VTAK
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 62% of VTAK (2026Q1)
- mediumEARNINGS_MISS
Q3-2024: Missed consensus by 9.5% - EPS $-38.19 vs $-34.884 estimate
- mediumEARNINGS_MISS
Q1-2025: Missed consensus by 71.6% - EPS $-6.65 vs $-3.876 estimate
- mediumEARNINGS_BEAT
Q1-2024: Beat consensus by 15.2% - EPS $-68.4 vs $-80.6208 estimate
- mediumEARNINGS_MISS
Q2-2024: Missed consensus by 107.6% - EPS $-105.83 vs $-50.9694 estimate
FREE, NO ACCOUNT
Every signal on VTAK, as it fires
You are seeing 5 of 7 signals recorded on VTAK since 2026-06-11.
The five above landed across 3 days. The other 2 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, VTAK
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
VTAK against its peers
VTAK's operating margin of -2581.6% ranks in the 26th percentile of 16 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | VTAK | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 819000 USD | 3.0M USD | 32 | 16 |
| Revenue YoY | n/a | -8.3% | n/a | 6 |
| Gross margin | 92.3% | 54.5% | 96 | 12 |
| Operating margin | -2581.6% | -124.2% | 26 | 16 |
| Net margin | -2098.0% | -197.3% | 26 | 16 |
| Return on equity | -243.6% | -210.8% | 35 | 12 |
| 1 year | n/a | -86.2% | n/a | 15 |
Peers (20): RMSL, VYCO, XAIR, POAS, NUWE, ESMC, NUMD, ADMT, BJDX, IVF, BTCY, TANAF, PFSA, ADGM, NXL, AIDX, STME, USAQ, VVOS, INBS. Left out: CSDX (no annual filing), FZMD (period gap), PMEDF (period gap), TRIB (period gap), SONX (period gap). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (VTAK: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow VTAK on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to VTAK for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.